Yan, M., Dong, Y., Bo, X., Cheng, Y., & Cheng, J. (2021). Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels. Frontiers Media S.A.
Cita Chicago Style (17a ed.)Yan, Meichen, Yuan Dong, Xuena Bo, Yong Cheng, y Jinbo Cheng. Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels. Frontiers Media S.A, 2021.
Cita MLA (8a ed.)Yan, Meichen, et al. Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels. Frontiers Media S.A, 2021.
Precaución: Estas citas no son 100% exactas.